𝔖 Bobbio Scriptorium
✦   LIBER   ✦

242 Phase I study of irinotecan (I), raltitrexed (R), and 5-fluorouracil (5FU) in the treatment of metastatic colorectal cancer (MCRC) refractory to thymidylate synthase inhibitors (TSI)

✍ Scribed by R. Goel; J. Maroun; C. Cripps; D. Jonker; G. Chiritescu; S. Dahrouge; L. Douglas

Book ID
118620417
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
165 KB
Volume
1
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I – II study to assess the feasibi
Phase I – II study to assess the feasibility and activity of the triple combination of 5-fluorouracil/folinic acid, carboplatin and irinotecan (CPT-11) administered by chronomodulated infusion for the treatment of advanced colorectal cancer. Final report of the BE-1603 study
✍ Focan, C.; Kreutz, F.; Graas, M.-P.; LongrΓ©e, L.; Focan-Henrard, D.; Demolin, G. πŸ“‚ Article πŸ“… 2013 πŸ› Elsevier Science 🌐 English βš– 429 KB
6096 POSTER FOLFOXIRI (Irinotecan, Oxali
6096 POSTER FOLFOXIRI (Irinotecan, Oxaliplatin, and Infusional 5FU/LV) in Combination With Panitumumab (P) in the First-line Treatment of Metastatic Colorectal Cancer (mCRC) Patients (pts) Selected for KRAS, BRAF, NRas and HRas Mutational Status – a Phase II Study by the G.O.N.O. Group
✍ Fornaro, L.; Loupakis, F.; Lonardi, S.; Masi, G.; Salvatore, L.; Cremolini, C.; πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 49 KB